Sage Therapeutics


Sage is committed to discovering, developing and delivering novel medicines to transform the lives of patients with life-altering disorders of the central nervous system (CNS). Sage has opened the door to a whole new way to think about treating disorders of the brain. Sage is proud to introduce Zulresso (brexanalone), a novel treatment for moms diagnosed with postpartum depression and is making it available throughout the federal healthcare system.  Please stop by our booth for information.

Exhibitor Level: 
Bronze Level
Booth Number: 
Exhibitor Type: